Results 241 to 250 of about 279,018 (287)

Bioprinting Organs—Science or Fiction?—A Review From Students to Students

Advanced Healthcare Materials, EarlyView.
Bioprinting artificial organs has the potential to revolutionize the medical field. This is a comprehensive review of the bioprinting workflow delving into the latest advancements in bioinks, materials and bioprinting techniques, exploring the critical stages of tissue maturation and functionality.
Nicoletta Murenu, Camilla Mussoni, Mateo S. Andrade Mier, Paula Buettner, Nathaly Chicaiza‐Cabezas, Yi‐Yu Robin Dai, Jessica Faber, Maren Fiedler, Zan Lamberger, Xuen Jen Ng, Vanessa Moessler, Anna Rederer, Jonas Roeder, Sabrina Stecher, Katinka Theis, Jeanette Weigelt, Silvia Budday, Gregor Lang, Natascha Schaefer   +18 more
wiley   +1 more source

Antibody-drug conjugates in cancer therapy: current landscape, challenges, and future directions. [PDF]

Mol Cancer
Chen B, Zheng X, Wu J, Chen G, Yu J, Xu Y, Wu WKK, Tse GMK, To KF, Kang W.   +9 more
europepmc   +1 more source

A hypothesis-generating study of the combination of aspirin plus macrolides in patients with severe community-acquired pneumonia [PDF]

, 2019
et al,, Jones, Christopher, Kollef, Marin   +2 more
core   +1 more source

Bioengineered Pancreatic Cancer Immunosuppressive Microenvironment Models for Screening Immunotherapies

Advanced Healthcare Materials, EarlyView.
Bioengineering tumor‐stroma pancreatic cancer models with potential to emulate the native immunosuppressive tumor microenvironment. Cancer‐on‐a‐bead models exhibited higher relevance for screening immunotherapies and modulating the protumoral PDAC microenvironment. ABSTRACT Pancreatic cancer is notably resistant to treatment, primarily due to its dense
Maria V. Monteiro, Margarida Henriques‐Pereira, Bruno M. Neves, Vítor M. Gaspar, João F. Mano   +4 more
wiley   +1 more source

Efficacy of larotrectinib in pediatric cancers with <i>NTRK</i> gene fusions. [PDF]

Transl Pediatr
Houghton PJ, Bjornsti MA.
europepmc   +1 more source

The Evolving Role of Second- and Third-Generation Tyrosine Kinase Inhibitors in Gastrointestinal Malignancies: Advances in Targeted Therapy with Sunitinib, Regorafenib, and Avapritinib. [PDF]

J Clin Med
Kawczak P, Bączek T.
europepmc   +1 more source

Transcriptional Profiling Reveals Lineage-Specific Characteristics in ATR/CHK1 Inhibitor-Resistant Endometrial Cancer. [PDF]

Biomolecules
Huang TT, Lee JM.
europepmc   +1 more source

Targeting CDK12/13 Drives Mitotic Arrest to Overcome Resistance to KRASG12C Inhibitors. [PDF]

Cancer Res
Stern YE, Ghosh P, Peroza J, Solanki HS, Imbody D, Bridenstine L, Pandurangan T, Frydman SM, Nickens KN, Walker-Mimms HL, Suvarna K, Chaudhary N, Monastyrskyi A, Duckett D, Haura EB.   +14 more
europepmc   +1 more source

Research progress on ferroptosis in drug resistance and therapy of gastric cancer. [PDF]

J Cancer Res Clin Oncol
Liu Y, Jia L, Yang L, Ning Z, Li Y.
europepmc   +1 more source